Global Patient Derived Xenograft/PDX Models Market: Overview

Xenograft tumor models are supposed to preserve original tumor characteristics such as heterogeneous histology, clinical biomolecular signature, malignant phenotypes and génotypes, tumor archive, and tumor vasculature at low passage. Xenographs derived from the patient are thought to provide appropriate clinical insights for evaluation of the effectiveness of novel cancer therapy, based on this prevalent hypothesis.

In the selection of appropriate PDX models and conditions for in vivo efficacy studies the material derived from PDX serves as time and cost effective tools. The PDX model can be developed directly through the implantation in an immune-deficient mouse of cancerous tissue from the tumor and thus preserves interactions between the cell and tumor microenvironments. In addition, as a pre-clinical model, the PDX model has demonstrated advantages in drug testing, biomarker growth and co-clinical studies.

This report gives step by step research into the global patient derived xenograft/PDX models market, focusing on market opportunities and possible constraints, along with the latest trends driving the market.

Global Patient Derived Xenograft/PDX Models Market: Trends and Opportunities

The segment of respiratory tumor models is valued to have the highest patient derived xenograft/PDX models market share in the coming years. Preclinical studies can be designed for the identification of lead candidates from several hits; develop the best new drug scale procedure; select the best formula; identify route, frequency and exposure duration; and, finally, support the desired clinical trial design. The segment of oncology and preclinical development is expected to continue as an upcoming and important trend that is expected to influence the global market for xenograft / PDX models for patients.

The preclinical development activities include the development of the Clinical Plan and the preparation of the drug product, including associated documentation, in order to comply with the regulatory guidelines of stringent FDA Good Manufacturing practices. Government programs, like Small Business Innovative Research and Small Business Technology Transfer grants and National Institutes of Health, provide funding and services for applicants in the preparation of their pre-clinical programs and documentation. In the coming years, the global market for xenograft / PDX derived patients will experience an upward trend.

Global Patient Derived Xenograft/PDX Models Market: Regional Outlook

A substantial share of the PDX model market in globally is expected to be held by the North American PDX models market. The regional market’s growth can be attributed to growing biomedical research in the United States, preclinical CRO and pharmaceutical businesses and stem cell research in Canada, along with increase in preclinical research.

The Asia Pacific market in the world's PDX model is expected to grow with the highest CAGR in the coming years. The projected growth of the market during coming years is a result of strong research expenditure and the well-structured CRO industry in China, the growth in biomedical and médical research in Japan, increased pharmaceutical R&D in India and increased translation and biomedical research in Singapore.                        

Global Patient Derived Xenograft/PDX Models Market: Competitive Landscape

The world patient derived xenograft/PDX models market is highly fragmented and the leading players have used various strategies for the improvement of the patient footprints in this market such as new products launchings, expansions, agreements, joint ventures and partnerships.

Charles River, Urolead,  Bioduro, xentech, Crown Bioscience Inc, EPO Berlin-Buch GmbH, Shanghai LIDE, Pharmatest Services,  Hera BioLabs, Horizon Discovery Group plc, Champion Oncology, Inc, Oncodesign, The Jackson Laboratory, and Xenopat, are some of the leading vendors in the global patient derived xenograft/PDX models market.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.